TERBINAFINE Comprimé

Land: Canada

Sprog: fransk

Kilde: Health Canada

Aktiv bestanddel:

Terbinafine (Chlorhydrate de terbinafine)

Tilgængelig fra:

SIVEM PHARMACEUTICALS ULC

ATC-kode:

D01BA02

INN (International Name):

TERBINAFINE

Dosering:

250MG

Lægemiddelform:

Comprimé

Sammensætning:

Terbinafine (Chlorhydrate de terbinafine) 250MG

Indgivelsesvej:

Orale

Enheder i pakken:

30/100

Recept type:

Prescription

Terapeutisk område:

ALLYLAMINES

Produkt oversigt:

Numéro de groupe d'ingrédients actifs (GIA) :0132855002; AHFS:

Autorisation status:

APPROUVÉ

Autorisation dato:

2016-06-01

Produktets egenskaber

0RQRJUDS LHH3URXLW7(5%,1 ),1(
3DJH
H
0212*53,( '(352'8,7
3U
7(5%,1),1(
RPSULPpVGH FKORUK GUDWH GH WHUELQDILQH
7HUELQDILQHj
PJ VRXV IRUPH GHFKORUK GUDWHGHIOXR[pWLQH
Q LIRQJLTXH
6LYHP 3URGXLWV 3KDUPDFHXWLTXHV8/
UXH 'REULQ
6DLQW /DXUHQW4XpEHFDQDGD
5 3
ZZZVLYHPFD
1XPpURGH FRQUOH GHODSUpVHQDLRQ
GpFHPEUH
DH GHUpYLVLRQ
0RQRJUDS LHH3URXLW7(5%,1 ),1(
3DJH
H
7DEOHGHVPDLqUHV
3 57,( ,
5(16(,*1(0(176 3285 /(352)(66,211(/
( /6 17e
5(16(,*1(0(1766200 ,5(6 685 /(352'8,7
,1',
7,216 (787,/,67,21/,1,48(
0,6(6(1*5'((735e87,216
())(76 ,1'e6,5%/(6
,17(57,216 0e',
0(17(86(6
3262/2*,( (7 02'( ''0,1,675 7,21
685'26
*(
02'( ' 7,21(73 502/2*,(/,1,48(
67%,/,7e (7
216(59 7,21
',5( 7,9(6 3 57,
8/,
5(6 '(0 1,38/7,21
)250(3262/2*,48(
20326,7,21 (7
21',7,211(0(17
3 57,( ,, 5(16(,*1(0(176 6,(17,),48(6
5(16(,*1(0(1763
50
(87,48(6
(66,6/,1,48(6
3502/2*,('e7 ,//e(
0,
52%,2/2*,(
72;,
2/2*,(
5e)e5(1(6
3 57,(,,,
5(16(,*1(0(176 3285 /(
2162007(85
0RQRJUDS LHH3URXLW7(5%,1 ),1(
3DJH
H
3U
7(5%,1),1(
RPSULPpVGH FKORUK GUDWH GH WHUELQDILQH
357,( , 5(16(,*1(0(1763285/(352)(66,211(/( /617e
5(16(,*1(0(1766200,5(6685/(352 8,7
9RLH
G DGPLQLVUDLRQ
)RUPHSRVRORJLTXH
7HQHXU
7RXV OHV LQJUpGLHQVQRQPpGLFLQDX
2UDOH
RPSULPpV GRVpV j
PJ GH WHUELQDILQH
VLOLFHFROORwGDOHDQK GUH
PpWK OK GUR[ SURS OFHOOXORVH VWpDUDWH GH
PDJQpVLXP FHOOXORVHPLFURFULVWDOOLQH
JO
FRODWHGDPLGRQVRGLTXH
,1,
7,216 (787,/,67,21/,1,48(
7(5%,1),1( FKORUK GUDWHGHWHUELQDILQH
HVW
LQGLTXp GDQV OH WUDLWHPHQW GHV LQIHFWLRQV
IRQJLTXHV GH OD SHDX HW
GHVRQJOHVSURYRTXpHV SDU GHV GHUPDWRSKWHVWHOV TXH
7ULFRS
WRQ
SDUH[HPSOH
7UXEUXP 7 PHQWDJURSWHV
7
HUURFRVXP 7
LR DFHXP
0LFURVSRUXP FDQLV
(SL
HUPRSWRQ IRFFRVXP HW OHV OHYXUHV GX JHQUH &DQLD SDU
H[HPSOH &DQLDDELFDQV
GH PrPH TXH 0DDVVH LDIXUIXU
7(5%,1),1( HVW LQGLTXpH GDQV OH WUDLWHPHQW GHV RQ FKRP FRVHV
LQIHFWLRQVIRQJLTXHV GH
O RQJOH FDXVpHV SDU GHV GHUPDWRSK WHV
YDQW GDPRUFHUOH WUDLWHPHQWSDU OHV FRPSULPpV 7(5%,1),1( LO IDXW
SUpOHYHU GHV
pFKDQWLOORQV GRQJOHV RX GH SHDX DX[ ILQV GHV DQDO
VHV GH ODERUDWRLUH
SUpSDUDWLRQ
G K GUR[ GH GH SRWDVVLXP>.2
FXOWXUH IRQJLTXH RX ELRSVLH